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Background: The diabetes prevalence increases at an alarming rate around the world and understanding disparities in
occurrence, care management, and health outcomes may be a starting point towards achieving more effective
strategies to prevent and manage it. The aims of this study are to compare immigrants and Italians in terms of the
differences in diabetes prevalence and to evaluate inequalities in disease management and glycaemic control by using
information included in Reggio Emilia diabetes register.
Methods: We retrieved from the diabetes register subjects aged 20–74 on December 31st, 2009. Using citizenship, we
created three main groups: Italy, High Developed Countries (HDC), and High Migration Pressure Countries (HMPC).
These were split into sub-regions of origin. We calculated age-adjusted prevalence by gender and sub-region. Using
logistic regression model, we analyzed the association between area of origin and following indicators: 1) not being in
care of diabetes clinics; 2) not having glycated haemoglobin (HbA1c) test in 2010; 3) among those tested, having a
HbA1c value > = 9% (75 mmol/mol).
Results: We found 15,889 Italian and 1,295 HMPC citizens with diabetes. HMPC citizens had higher age-adjusted
prevalence of diabetes than Italians (females 5.0% vs 3.6%; males 6.5% vs 5.5%). The excess was mostly due to a strong
excess in immigrants from Southern Asia (females 9.7%, males 10.2%) and Northern Africa (females 9.3%, males 5.9%).
HMPC citizens were cared for by diabetes clinics in a similar proportion than Italians (OR: 1.08; 95% CI: 0.93-1.25), but
had a greater odds of not being tested for HbA1c (OR: 1.51; 95% CI: 1.34-1.71), as well as of having HbA1c values equal
to or over 9% (OR: 2.06; 95% CI: 1.80-3.14). The outcomes were poorer in HMPC females for the first two outcomes,
while there was no difference for the HbA1c values (Wald test for heterogeneity p = 0.0850; p = 0.0156; p = 0.6635,
respectively).
Conclusions: Our findings highlight the need for gender-oriented actions for prevention and early diagnosis of
the diabetes to contrast the higher risk in Northern Africans and Southern Asians. Further studies are required to
determine whether the protocols in use are adequate for different immigrant groups.
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Diabetes is a major health problem that is increasing at
an alarming rate around the world. In 2013, 382 million
people had diabetes; this number is expected to rise to
592 million by 2035, potentially leading to major medical,
social, and economic problems [1]. Understanding dispar-
ities in occurrence, care management, and health out-
comes may be a starting point towards achieving more
effective strategies to prevent and manage diabetes.
International studies provide strong evidence that eth-
nicity is an important determinant of diversity in the oc-
currence of diabetes [2-11]. In addition, studies have
shown that immigrants with diabetes are undermanaged
[12-14], and some ethnic groups have a lower probability
of testing glycaemic index and reaching the recom-
mended levels of glycated haemoglobin (HbA1c) [15-18].
As with other diseases, the relationship between diabetes
and migration can be difficult to disentangle as the
former is influenced by ethnic, socioeconomic, lifestyle,
individual factors, and the latter by the country of origin,
reasons for migration, age at arrival, and duration of stay
in the host country.
In Italy, the foreign population has grown steadily over
the years, from 0.6% of the resident population in 1991
to 7.0% in 2009 [19-21]. In Reggio Emilia (northern
Italy) province, the percentage of immigrants was 12.3%
at the end of 2009, one of the highest in Italy [20,21].
Further, the immigrant population is very heterogeneous,
with people from more than 100 countries. The first
three largest communities (i.e. Morocco, Albania, India)
together account only for 36% of the foreigners.
The aims of our study are to compare immigrants and
Italians in terms of the differences in diabetes prevalence
and to evaluate inequalities in disease management and
glycaemic control by using information included in
Reggio Emilia diabetes register.
Methods
Setting and study population
Reggio Emilia is a province situated in Emilia-Romagna
region, northern Italy. The health system is administered
by the local health authority; the province is divided in
six health districts. The local health authority of Reggio
Emilia is a partner of the International Network of
Health Promoting Hospitals & Health Services (HPH)
and leader of the Task Force on Migrant Friendly and
Culturally Competent Health Care (TF MFCCH). As con-
sequence of this immigrant-sensitive strategy, the local
health authority management has over the years encour-
aged studies aimed at monitoring immigrant health status
and health services utilization.
For the present study we took into consideration all
inhabitants in the Reggio Emilia province aged 20–74 on
December 31st, 2009: 369,435 individuals. Of these, therewere 17,195 subjects who had been diagnosed with dia-
betes on or before December 31st, 2009, were alive on
that date, and were included in the Reggio Emilia dia-
betes register (accessed on November, 8th, 2013),
achieving a prevalence of 4.6%. The methods applied to
develop our disease register have been described else-
where [22]. In brief, the register was created by deter-
ministic linkage of six routinely collected data sources
through a definite algorithm able to ascertain cases and
to distinguish type of diabetes and model of care. The
sources are: Hospital Discharge, Drug Dispensation,
Biochemistry Laboratory, Disease-specific Exemption,
Diabetes Outpatient Clinics, and Mortality databases.
Women with gestational diabetes or women receiving
treatment for polycystic ovarian syndrome were excluded.
There are 7 diabetes outpatient clinics in the Reggio
Emilia province that provide specialized care for diabetes
patients. Regional disease management guidelines [23]
recommend that patients with Type 1 diabetes are al-
ways followed by diabetes outpatient clinic or paediatric
unit. According to regional guidelines, newly diagnosed
Type 2 diabetes patients are referred by their general
practitioner (GP) to diabetes clinics for a preliminary
evaluation. The specialist at diabetes clinic identifies
those patients eligible for shared care management (in
the case of well-controlled Type 2 diabetes) and those
that should be cared for exclusively by a diabetes clinic
(i.e. in the case of diabetes with chronic complications,
insulin therapy, or unstable control of disease). Conse-
quently, the patients not in care of diabetes clinics
could either be in the care of their GP only or not cared
for at all.
Outcomes and other variables
According to the regional guidelines [23], we calculated
two indicators of disease management and one indicator
as intermediate outcome of care: 1) the percentage of
people with diabetes who were not in care of diabetes
clinics; 2) the percentage of those who had not at least
one HbA1c test in 2010 (excluding those who had died
or moved away in that year); 3) among those tested, the
percentage with the most recent HbA1c value equal to
9% (75 mmol/mol) or over (marker of very poor gly-
caemic control according to regional guidelines [23,24]).
The results are presented by sex and citizenship, and
grouped by geographical area of origin. First, we aggre-
gated the citizenships into three main groups: Italy,
High Developed Countries (HDC), and High Migration
Pressure Countries (HMPC) [25]. Then, in accordance
with the UN geoscheme [26], we split HMPC in sub-
regions of provenience: Europe no HDC, Northern Africa,
sub-Saharan Africa, Southern Asia, Rest of Asia, LA and
the Caribbean. Annex 1 (Additional file 1) details country
classification by area of origin, reporting for each country
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diabetes, and crude prevalence. Subjects with diabetes
were dichotomized as “not treated” if no drug prescription
was found in our databases in 2009–2010 or “treated” if
anti-diabetic drug (insulin or oral hypoglycaemic) pre-
scriptions were found.
Statistical analyses
We calculated age-adjusted point prevalence rates of
diabetes by sex and sub-region on December 31st, 2009.
To perform direct age-standardization, we used the 2009
Reggio Emilia population in order to adjust for differ-
ences in population distribution across different world
sub-regions.
Furthermore, we computed the mean age with confi-
dence intervals and we reported the number and percent-
age of subjects not treated with anti-diabetic drugs, not in
care of diabetes clinics, without HbA1c test in 2010, and,
among those tested, with latest HbA1c assay > = 9%
(75 mmol/mol).
Lastly, we used the multivariate logistic regression
model to analyze the association between immigrant sta-
tus and the outcomes defined above, using Italian citi-
zenship as comparator and adjusting for age (kept as
continous variable), sex, and treatment. In the analysis
by sub-region, sex was included in the model as further
covariate. To evaluate the interaction between main
groups of citizenship and sex, a Wald test was applied.
To investigate whether having a prescription of anti-
diabetes drugs was a possible intermediate factor be-
tween the exposure variable “citizenship” and the out-
come variable “having HbA1c > = 9% (75 mmol/mol)”,
we show the results of logistic model with and without
the treatment as covariate. A 5% significance level was
used for all analyses. Analyses were performed using the
STATA statistical package Version 11.
Ethical approval
This is an observational study and data were collected
retrospectively. The local health authority of Reggio
Emilia was responsible for collecting and elaborating
these data. The study was commissioned by the local
health authority. The Reggio Emilia diabetes registry was
approved by the provincial Ethical Committee in July
2014. According to Italian privacy law, no patient’s or
parents’ consent is required for large retrospective
population-based studies and when data are published
only in aggregated form.
Results
Prevalence
In our register, we found 15,889 (92.4%) Italians, 11 citi-
zens from HDC (0.1%), and 1,295 (7.5%) from HMPC
with diabetes and aged 20–74. There were 15,151 (95.3%),9 (81.8%), and 1,225 (94.6%) subjects with Type 2 dia-
betes, respectively. Foreigners were younger than Italians
(Table 1), and the lowest age means were found among
men and women from sub-Saharan Africa (F: mean
44.6 years, 95% CI: 41.4-47.9; M: mean 44.9 years, 95% CI:
43.2-46.7).
For both sexes, citizens of HMPC experienced signifi-
cantly higher prevalence of diabetes than did Italians
(F: 5.0% vs 3.6%; M: 6.5% vs 5.5%), whereas for citizens
from HDC, the occurrence of diabetes was smaller
(Figure 1 and Table 1). The excess of prevalence in
HMPC was mostly due to a strong excess in immi-
grants from Southern Asia and Northern Africa.
For Italians the prevalence was higher in males than
in females, with a similar pattern seen in people from
Eastern Europe (Europe no HDC). For Africans, both
North and Sub-Saharan, instead, the prevalence was
higher in females. People from other areas did not show
any difference between sexes.
Disease management and glycaemic control
The proportion of Italians and of immigrants from
HMPC for whom no drug prescription was found was
similar, as was the proportion of subjects not followed
by diabetes clinics (Table 1).
Instead, the percentage of Italians who did not per-
form HbA1c test was lower than it was for foreigners.
Among HMPC, almost one out of two subjects had not
been tested, excluding the citizens from Southern Asia,
who had lower proportion of not tested, although still
higher than that of Italians.
Ethnic differences were also noticeable when observing
percentages of subjects with HbA1c test equal to 9%
(75 mmol/mol) or over: for both sexes, the proportion
for the HMPC was more than double that for Italians.
Broken down into sub-regions, women from Southern
Asia and sub-Saharan Africa and men from Latin America
had the worst indicators.
The results of multiple logistic regression (Table 2)
show differences between Italians and immigrants from
HMPC. We did not perform analysis for HDC because
the population with diabetes was too small to be
investigated.
In comparison with their Italian counterparts, HMPC
had a similar odds of not being followed by a diabetes
clinic, while both sexes from HMPC had a greater odds
of not being tested for HbA1c compared to Italians, as
well as of having unsatisfactory control of disease (i.e.
HbA1c value equal 9% or over). The results do not sub-
stantially change using 7.5% (58 mmol/mol) cut-off [27]:
OR adjusted for age, treatment and sex: 1.59; 95% CI:
1.34-1.88.
The outcomes were poorer in female from HMPC for
access to diabetes clinics and for HbA1c testing, while
Table 1 Characteristics of subjects with diabetes on December 31st, 2009: 20–74 years
Area of origin
(n. of subject with
diabetes)






Crude Adjusted 95% CI Mean 95% CI N % N % N % N %
Italy (15,889) F 4.1 3.6 3.5-3.7 62.0 61.7-62.2 1,423 21.9 1,455 22.3 1839 28.6 586 12.6
M 5.8 5.5 5.4-5.6 61.2 61.0-61.4 1,982 21.1 2,083 22.2 2892 31.5 769 12.0
HDC (11) F 2.1 2.2 0.4-4.0 51.8 43.7-60.0 1 14.3 1 14.3 2 33.3 1 25.0
M 7.5 1.7 0.1-3.4 61.2 55.9-66.1 1 25.0 1 25.0 2 50.0 0 0.0
HMPC (1,295) F 2.7 5.0 4.5-5.5 50.8 49.9-51.8 133 21.5 155 25.1 288 47.1 94 29.0
M 3.1 6.5 5.8-7.1 48.6 47.8-49.4 117 17.3 128 18.9 285 42.5 104 26.9
Europe no HDC (281) F 1.8 3.1 2.5-3.7 54.9 53.2-56.5 31 18.9 50 30.5 84 51.5 11 13.9
M 1.9 5.3 4.3-6.4 55.2 53.1-57.4 14 12.0 26 22.2 48 41.4 14 20.6
Northern Africa (396) F 5.6 9.3 8.0-10.6 50.8 49.0-52.6 43 21.2 59 29.1 100 49.7 30 29.7
M 3.5 5.9 4.8-7.0 48.6 47.3-50.0 32 16.6 47 24.3 95 50.3 22 23.4
Sub-Saharan Africa F 3.0 6.5 3.7-9.3 44.6 41.4-47.9 11 23.4 9 19.1 22 47.8 9 37.5
(114) M 3.4 4.3 2.1-6.5 44.9 43.2-46.7 12 17.9 9 13.4 31 46.3 10 27.8
Southern Asia (378) F 4.6 9.7 7.9-11.5 48.8 46.7-50.9 36 26.9 21 15.7 47 35.6 36 42.3
M 5.8 10.2 8.4-11.9 46.7 45.5-48.0 52 21.3 34 13.9 83 34.3 48 29.8
Rest of Asia (94) F 1.9 4.5 2.5-6.5 48.4 44.9-51.9 8 17.0 11 23.4 26 55.3 4 19.0
M 2.3 3.9 2.4-5.4 46.9 43.9-49.8 7 14.9 9 19.1 23 48.9 8 33.3
LA and the Caribbean F 2.7 4.3 2.2-6.4 51.7 47.5-56.0 4 17.4 5 21.7 9 39.1 4 28.6
(32) M 3.4 3.2 1.1-5.2 48.6 41.0-56.1 0 0.0 3 33.3 5 55.6 2 50.0












Figure 1 Age-adjusted prevalence (with 95%CI) by gender and
sub-region on December 31st, 2009. Age 20–74. Diabetes register
did not include citizens of Oceania and Stateless. Green squares are
male prevalence and orange triangles are female prevalence. The
green dot axis is the overall male crude prevalence (5.4%) and the
orange solid axis is the overall female crude prevalence (3.9%).
Table 2 Odds ratios^ (with 95% CI) for quality of care indicato
Female
Indicators OR 95% CI
Not in care of diabetes clinics 1.22 0.98-1.50
Without HbA1c test in 2010* 1.84 1.54-2.20
Among tested, HbA1c > =9%
Adjusted by age 2.32 1.77-3.05
Adjusted by age and treatment 2.38 1.80-3.14
^Odds ratios (OR) and 95% confidence intervals (95% CI) were obtained using logis
performed analysis with and without treatment as covariate). Italy was used as com
*Excluding those who died or moved in 2010 (n = 302).
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for heterogeneity p = 0.0850; p = 0.0156; p = 0.6635,
respectively).
In the analysis by different sub-regions (Figure 2), we
found that subjects from Northern Africa experienced
higher odds for all indicators compared to Italians (“not
being in care of diabetes clinics”: OR = 1.42; 95% CI:
1.12-1.80; “without HbA1c test in 2010”: OR = 1.91; 95%
CI: 1.55-2.35; “among those tested, HbA1c >=9%”: OR =
1.92; 95% CI: 1.37-2.69, respectively).
The Southern Asians seemed to use the diabetes clinic
more than did Italians (OR = 0.61; 95% CI: 0.46-0.83),
while there was no difference in terms of test execution
(OR = 0.92; 95% CI: 0.74-1.15), although the former had
worse glycaemic control (OR = 2.84; 95% CI: 2.13-3.79),
more markedly so for women than for men (OR = 4.97;
95% CI: 3.06-8.07 and OR = 2.06; 95% CI: 1.42-2.98, data
not shown in the figure). Very poor glycaemic control
was common to all sub-regions except Europe no HDC.
Discussion
Prevalence
Our study used population-based data retrieved from a
disease register in a setting with remarkable rates of im-
migration. We observed a significantly higher prevalence
for HMPC citizens than for Italians, and lower preva-
lence for citizens from HDC countries. The prevalence
was particularly high for North Africans and Southern
Asians. Our findings are consistent with similar studies
conducted in Europe [2,4,7-11], in Canada [3,5], in the
USA [28], and in Australia [6]. The high prevalence of
diabetes in specific ethnic migrant groups are likely
attributable to a complex interplay of genetic and envir-
onmental factors, including acculturation, stress, social
isolation, and employment and economic challenges
[3,29]. In addition, people from Southern Asia seem to
have a genetic susceptibility to Type 2 diabetes [30,31].
Furthermore, some authors have suggested that hypovi-
taminosis D, particularly relevant in migrant groups with
darker skin pigmentation, increases the risk of diabetes
in Africans [32,33].rs, age 20–74
Male Total
OR 95% CI OR 95% CI
0.95 0.77-1.17 1.08 0.93-1.25
1.29 1.09-1.53 1.51 1.34-1.71
1.94 1.50-2.50 2.12 1.76-2.55
1.82 1.41-2.35 2.06 1.80-3.14
tic regression model with age and treatment covariates (for third outcome we
parator.
Figure 2 Adjusted odds ratios (with 95% CI) for quality of care indicators by sub-region on December 31st, 2009. Age 20–74. OR and
95% CI were obtained using multiple logistic regression model with age, treatment, and sex as covariates. Italians were used as reference. OR
estimation for Hb1Ac test excludes those who died or moved in 2010 (n = 302).
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than women in Italians, HMPC women in our study had
prevalence rates that were roughly equivalent to or
higher than those of men from the same countries. Par-
ticularly high prevalence was evident among women
from Northern Africa compared to men, and, with a
smaller gap, among women from sub-Saharan Africa.
This pattern, founded previously in Canada, Sweden,
and France [2,3,34], suggests that gender plays a role as
effect modifier in the relationship between ethnicity and
diabetes in non-western countries. A higher prevalence
of diabetes in women can be related to a higher rate of
obesity and physical inactivity, especially high among
women of non-western origin [35,36].
Women from Northern Africa and Southern Asia usu-
ally migrate to Italy with their husbands, who seek job
opportunities. For example, in 2007, the percentage of
residence permits for family reunion issued to Tunisian
women was 83.2% and to Indian women 70.1%, while the
general percentage was 48.4% [37]. The host environment
may reduce the need for physical activity to housework
[26] and introduce a more caloric diet, thus contributing
to the higher risk of overweight, obesity, and diabetes.Italian diabetes guidelines recommend initial screening
for diabetes at age 45 years [38], although an opportun-
istic screening at younger age is recommended for pa-
tients belonging to an ethnic group at high risk. Our
study confirms the rationale of these recommendations
and identifies the ethnic groups particularly at risk, as
well as North African women and Southern Asians of
both sexes.
Disease management and glycaemic control
Our study did not find any differences between Italians
and immigrants in the access of diabetes clinics as a
whole, although North Africans proved to use the clinics
less than did Southern Asians, who used the clinics
more than did Italians. This could be due in part to a
general difficulty for immigrants in accessing to primary
care, and particularly to the GP or family paediatrician
[39]. An Irish study conducted among asylum seekers
[40] found that they were more likely to be referred to
outpatient services for various medical conditions than
were their Irish counterparts.
As regards recent measurement of HbA1c, HMPC
were less likely to perform the annual test, the difference
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regions revealed that among HMPC, only Southern
Asians had a level of compliance to guidelines similar to
that of Italians.
Concerning glycaemic control, HMPC fared worse than
did Italians, with the difference once again being more
marked for women. For this intermediate outcome, only
immigrants from Europe no HDC experienced values
similar to those of Italians. Surprisingly, Southern Asians
had the worst outcomes in terms of glycaemic control,
despite their being the ones who most frequently cared for
by specialized diabetes clinics and who seemed to be the
most compliant to guidelines for HbA1c testing. Some au-
thors suggest that one important factor contributing to in-
creased Type 2 diabetes in Asian Indians is excessive
insulin resistance compared to Caucasians. This difference
in the degree of insulin resistance may be explained by ei-
ther an environmental or a genetic factor or by combin-
ation of both [27,28]. Our findings confirm the studies
carried out in the UK [13,16,41,42], in Sweden [18], in the
USA [15,17], and in Italy [12]. Gray and Heisler did not
find any significant difference in frequency of measure-
ment, while Buja underlined less coverage in terms of
HbA1c for HMPC compared with Italians. The other
studies, focusing on glycaemic control, found worse values
for non-white ethnic groups.
Thabit [14] argued in his study that poor levels of
health literacy can negatively impact the patients’ ability
to interpret blood glucose levels, understand educational
materials, and read labels on medication, irrespective of
the patient’s educational level when operating in the for-
eign language. The same author suggested that health
knowledge and perceptions about managing diabetes
may be conceptualized differently in ethnic minorities
compared to the majority population.
A possible explanation may be that, in our setting, im-
migration is a relatively recent phenomenon and conse-
quently the patients from HMPC on average have been
into the care of diabetes clinics for less time compared
to Italians. As a result, the higher level of HbA1c could
reflect a higher proportion of newly diagnosed and
newly treated patients. Nevertheless, it must be noted
that all the differences in control of disease have been
observed even when we adjusted for treatment.
Strengths and limitations
In our knowledge, this is the first study carried out in
Southern Europe based on diabetes register that is able
to determine both age-standardized prevalence and qual-
ity of care indicators for immigrants and for different
geographical area of origin, using gender approach.
Nevertheless, as the information about diabetes onset
is not completely consistent, we decided not include this
variable in the analysis. As proxy of disease severity weused diabetes treatment regimen, distinguishing between
subjects using diet only and those treated with antidia-
betic drugs. In addition, we had no information about
the socioeconomic status of diabetic patients or about
their BMI values or other clinical characteristics.
Conclusions
Our study confirms the higher diabetes prevalence in im-
migrants from HMPC countries, especially for Southern
Asian citizens and for women from Northern Africa.
When comparing Italians with immigrants from HMPC,
although there was almost no difference in access of spe-
cialized level of care, the latter were less compliant and
more likely to experience worse levels of HbA1c. The fail-
ure in disease control is of particular concern, as immi-
grant patients are quite young and thus their duration of
disease will be quite long, thereby leading to potentially
more severe diabetes complications.
Our findings highlight the need for special, gender-
oriented actions for prevention and early diagnosis of
diabetes to contrast the higher risk in Northern Africans
and Southern Asians. Further studies are also required
to determine whether the protocols in use are adequate
for diabetes control but need to be better implemented
or whether different protocols and treatment for dia-
betes in some ethnic groups are needed.
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